Published by Josh White on 26th February 2024
(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.
URL: http://www.digitallook.com/dl/news/story/34111993/...